Accessibility Menu

Bio-Rad Laboratories(NYSE) BIOB

Current Price$0.00
Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1980)+12,702%
5 Year-54%
1 Year+20%
1 Month+2%
Bio-Rad Laboratories last closing stock price
MetricPriceDate
Last closeUSD 309.372026-07-20
Bio-Rad Laboratories stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 309.372026-07-13
1 month+1.72%USD 304.152026-06-18
3 month+11.69%USD 277.002026-04-21
Year to date-0.43%USD 310.702025-12-31
1 year+20.03%USD 257.752025-07-18
3 year-20.17%USD 387.552023-07-17
5 year-54.18%USD 675.252021-07-21
Since inception+12,701.69%USD 2.421980-02-25

Bio-Rad Laboratories Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

BIOB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Industry

Life Sciences Tools and Services

BIOB Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,471.79+0.00%
^DJIDJI
$51,968.92-0.00%
^IXICNASDAQ
$25,642.86+0.00%
BTCBitcoin
$65,680.00+0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.68+0.06%
UTZUtz Brands
$14.11+0.89%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$35.46+0.25%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.30-0.06%

Questions About BIOB

What is the current price of Bio-Rad Laboratories?

Bio-Rad Laboratories is trading at N/A per share.

What is the 52-week range for Bio-Rad Laboratories?

Over the past 52 weeks, Bio-Rad Laboratories has traded between N/A and N/A.

How much debt does Bio-Rad Laboratories have?

Bio-Rad Laboratories total debt is unavailable.

How much cash does Bio-Rad Laboratories have on hand?

Bio-Rad Laboratories does not have cash on hand data available.

What is Bio-Rad Laboratories’s dividend yield?

Bio-Rad Laboratories does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.